Concepedia

K. Miller

KM

3

Publications

263

Citations

3

H-Index

2006

Active since

K. Miller is an author specializing in radiation oncology, breast cancer, and oncology.

Top concepts

MedicineOncologyBreast CancerCancer TherapyRadiation OncologyHealthCancer ResearchClinical TrialsPathologyLung Cancer

Publications per year

2006–2010

3

Publications

3

A randomized phase III trial of paclitaxel with or without bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer: Eastern cooperative oncology group trial E2100

Robin Zoň, K. Miller, M. Wang et al. · European Journal of Cancer Supplements · 2006 · 135 citations

First-line Therapy, Metastatic Breast Cancer, Breast Oncology +7

A meta-analysis of overall survival data from three randomized trials of bevacizumab (BV) and first-line chemotherapy as treatment for patients with metastatic breast cancer (MBC).

J. O’Shaughnessy, David Miles, Robert J. Gray et al. · Journal of Clinical Oncology · 2010 · 110 citations

Breast Oncology, Cancer Management, Clinical Endpoint +19

Phase I study of imetelstat (GRN163L) in combination with paclitaxel (P) and bevacizumab (B) in patients (pts) with locally recurrent or metastatic breast cancer (MBC).

M. Kozloff, G. W. Sledge, Fabio Benedetti et al. · Journal of Clinical Oncology · 2010 · 18 citations

Tumor Biology, Stem Cell Compartment, Metastatic Breast Cancer +14

Rows per page

1–3 of 3